Page last updated: 2024-09-05

dofequidar and Carcinoma, Epidermoid

dofequidar has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimura, T; Tatsumi, M; Tsuruo, T1

Other Studies

1 other study(ies) available for dofequidar and Carcinoma, Epidermoid

ArticleYear
Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression; Genes, MDR; Humans; KB Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tissue Distribution

2002